CHILDREN'S DIMETAPP LONG-ACTING COUGH PLUS COLD OTC
Generic Name and Formulations:
Chlorpheniramine maleate 1mg, dextromethorphan HBr 7.5mg; per 5mL; syrup; grape-flavor; alcohol-free; contains sodium 3mg/5mL.
Pfizer Consumer Healthcare
Indications for CHILDREN'S DIMETAPP LONG-ACTING COUGH PLUS COLD:
Rhinorrhea, allergy symptoms, cough.
20mL every 6 hours; max 4 doses/24 hours.
<6yrs: do not use. 6–11yrs: 10mL every 6 hours; max 4 doses/24 hours.
Children <6yrs old. During or within 14 days of MAOIs. For use as a sedative hypnotic.
GI or GU obstruction. Glaucoma. Asthma. Lower respiratory disorders. Pregnancy. Nursing mothers.
Antihistamine + antitussive.
See Contraindications. Hypertensive crisis with MAOIs. Avoid alcohol. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, excitability in children.
Syrup—4oz (w. dosing cup)
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Serious Adverse Events Profile for Cladribine Confirmed With Extended Data
- Oxidized Low-Density Lipoprotein May Predict Risk for Recurrent Stroke
- Inappropriate Prescribing Protocols in Parkinson Disease
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
- Review of Factors Impacting Sport-Related Concussion Headaches
- Congress Passes Bill to Fight Opioid Crisis